| Dr Clifton D Cokingtin, MD | |
|
5520 College Blvd, Ste 201, Overland Park, KS 66211-1658 | |
| (913) 491-3737 | |
| (913) 469-6686 |
| Full Name | Dr Clifton D Cokingtin |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 5520 College Blvd, Overland Park, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427054758 | NPI | - | NPPES |
| 102258 | Other | KS | BCBSKS |
| 18344010 | Other | FREEDOM NETWORK | |
| 18344010 | Other | BCBSKC | |
| 3115147010 | Other | CIGNA | |
| 000314 | Other | FAMILY HEALTH PARTNERS | |
| 560000 | Other | FIRST GUARD | |
| 100138550D | Medicaid | KS | |
| 203405428 | Medicaid | MO | |
| 100138550C | Medicaid | KS | |
| 0808020 | Other | UNITED HEALTHCARE | |
| 18344010 | Other | PHP | |
| 203405444 | Medicaid | MO | |
| 4479577 | Other | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 04-24794 (Kansas) | Primary |
| Entity Name | Cokingtin Eye Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548228406 PECOS PAC ID: 9739182841 Enrollment ID: O20060810000188 |
News Archive
Oncolytics Biotech Inc. today announced that it has been granted its 30th U.S. Patent, # 7,452,723, entitled "Methods for Preventing Reovirus Recognition for the Treatment of Cellular Proliferative Disorders.
Navigation in mammals including humans and rodents depends on specialized neural networks that encode the animal's location and trajectory in the environment, serving essentially as a GPS, findings that led to the 2014 Nobel Prize in Medicine.
The Columbus Dispatch: "Gov. Ted Strickland's administration announced today that nearly $200 million in recently freed up state funds will go to Ohio hospitals, community mental health services, and a program which provides medication to low-income residents with HIV/AIDS. … The state money became available after Congress agreed to continue paying a higher share of the cost of state Medicaid programs that provide insurance coverage to the poor.
The ongoing coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused over 190 million cases worldwide. Of these, over 4 million have died due to the infection.
Database enhancements developed at The Cancer Institute of New Jersey (CINJ) are helping physicians use technology to further ensure safety in the delivery of chemotherapy.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Clifton D Cokingtin, MD 5520 College Blvd, Ste 201, Overland Park, KS 66211-1658 Ph: (913) 491-3737 | Dr Clifton D Cokingtin, MD 5520 College Blvd, Ste 201, Overland Park, KS 66211-1658 Ph: (913) 491-3737 |
News Archive
Oncolytics Biotech Inc. today announced that it has been granted its 30th U.S. Patent, # 7,452,723, entitled "Methods for Preventing Reovirus Recognition for the Treatment of Cellular Proliferative Disorders.
Navigation in mammals including humans and rodents depends on specialized neural networks that encode the animal's location and trajectory in the environment, serving essentially as a GPS, findings that led to the 2014 Nobel Prize in Medicine.
The Columbus Dispatch: "Gov. Ted Strickland's administration announced today that nearly $200 million in recently freed up state funds will go to Ohio hospitals, community mental health services, and a program which provides medication to low-income residents with HIV/AIDS. … The state money became available after Congress agreed to continue paying a higher share of the cost of state Medicaid programs that provide insurance coverage to the poor.
The ongoing coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused over 190 million cases worldwide. Of these, over 4 million have died due to the infection.
Database enhancements developed at The Cancer Institute of New Jersey (CINJ) are helping physicians use technology to further ensure safety in the delivery of chemotherapy.
› Verified 2 days ago
Dr. Richard Noxon Barr, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: #20 Wycklow, Overland Park, KS 66207 Phone: 913-649-1277 | |
Mr. William N Rosenthal, M.D.F.A.C.S. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10740 Nall Avenue, Suite 220, Overland Park, KS 66211 Phone: 913-663-5900 Fax: 913-663-5902 | |
Dr. Timothy B Cavanaugh, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6200 W 135th St, Suite 300, Overland Park, KS 66223 Phone: 913-897-9200 Fax: 913-897-9233 | |
Austin Andersen, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 11121 W 95th St, Professional Eyecare, Overland Park, KS 66214 Phone: 913-492-7728 Fax: 913-492-5217 | |
Jason E Stahl, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 8300 College Blvd., Suite 201, Overland Park, KS 66210 Phone: 913-491-3330 Fax: 913-491-9650 | |
Jemshed A Khan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9650 Nall Ave, Overland Park, KS 66207 Phone: 913-696-1154 Fax: 913-696-0984 | |
Ann C Stechschulte, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7200 W 129th St, Overland Park, KS 66213 Phone: 913-897-9299 Fax: 913-897-3031 |